Vanguard Russell 2000 Growth ETF (VTWG)

119.05 +5.34  +4.70% NASDAQ Apr 8, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 119.41
Discount or Premium to NAV -0.30%
Turnover Ratio 28.00%
1 Year Fund Level Flows 9.092M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -15.57% -15.30% -17.84% 65
3M -23.68% -23.49% -25.18% 64
6M -12.18% -11.57% -16.88% 52
YTD -23.44% -23.19% -24.89% 65
1Y -17.83% -17.50% -19.67% 62
3Y 1.71% 1.83% 1.97% 62
5Y 2.16% 2.23% 2.69% 69
10Y -- -- 8.53% --
15Y -- -- 7.06% --
20Y -- -- 5.35% --
As of April 8, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.24% 2.24% 0.00%
Stock 97.76% 97.76% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 29, 2020

Region Exposure

Americas 99.72%
North America 99.54%
Latin America 0.18%
Greater Europe 0.19%
United Kingdom 0.07%
Europe Developed 0.08%
Europe Emerging 0.04%
Africa/Middle East 0.00%
Greater Asia 0.09%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.09%
Asia Emerging 0.00%
Market Classification
% Developed Markets 99.96%
% Emerging Markets 0.04%
As of Feb. 29, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.08%
Communication Services 2.93%
Consumer Cyclical 9.76%
Consumer Defensive 4.22%
Energy 0.47%
Financial Services 5.79%
Healthcare 30.74%
Industrials 18.88%
Real Estate 4.78%
Technology 17.82%
Utilities 1.53%
As of Feb. 29, 2020

Stock Market Capitalization

Giant 0.00%
Large 0.40%
Medium 23.10%
Small 67.98%
Micro 8.52%
As of Feb. 29, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.41%
Mid Cap Value 1.17%
Mid Cap Blend 7.50%
Mid Cap Growth 14.99%
Small Cap Value 8.02%
Small Cap Blend 22.60%
Small Cap Growth 45.31%
As of Feb. 29, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
TDOC Teladoc Health Inc 0.91% 139.10 -1.52%
NVCR NovoCure Ltd 0.63% 69.50 +7.69%
GNRC Generac Holdings Inc 0.63% 96.35 +7.49%
TREX Trex Co Inc 0.56% 84.75 +15.10%
HAE Haemonetics Corp 0.56% 100.68 +5.35%
AMED Amedisys Inc 0.55% 184.55 +5.79%
HQY HealthEquity Inc 0.49% 50.85 +10.54%
DECK Deckers Outdoor Corp 0.49% 145.08 +2.77%
ACAD ACADIA Pharmaceuticals Inc 0.48% 42.80 +2.61%
EGP EastGroup Properties Inc 0.48% 106.54 +5.14%
As of Feb. 29, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization growth stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the Russell 2000® Growth Index. The index is designed to measure the performance of small-capitalization growth stocks in the United States. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Small Company
Fund Owner Firm Name Vanguard
Benchmark Index
Russell 2000 Growth TR USD 100.0%
Russell 2000 Growth TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Michael Johnson 4.11 yrs
Michael Johnson 4.11 yrs
Walter Nejman 4.42 yrs
Walter Nejman 4.42 yrs

Net Fund Flows

1M -142618.0
3M -8.213M
6M 37.03M
YTD -8.213M
1Y 9.092M
3Y 201.98M
5Y 340.49M
10Y --
As of March 31, 2020

Risk Info

Beta (5Y) 1.271
Max Drawdown (All) 40.36%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.5192
30-Day Rolling Volatility 90.42%
Daily Value at Risk (VaR) 1% (All) 3.54%
Monthly Value at Risk (VaR) 1% (All) 18.42%

Fundamentals

Dividend Yield TTM (4-8-20) 1.00%
30-Day SEC Yield (4-7-20) 0.48%
7-Day SEC Yield --
Weighted Average PE Ratio 22.83
Weighted Average Price to Sales Ratio 1.601
Weighted Average Price to Book Ratio 3.684
Weighted Median ROE 4.19%
Weighted Median ROA -1.92%
Forecasted Dividend Yield 0.88%
Forecasted PE Ratio 19.29
Forecasted Price to Sales Ratio 1.428
Forecasted Price to Book Ratio 3.172
Number of Holdings 1182
As of Feb. 29, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 13.00%
Forecasted Book Value Growth 8.37%
Forecasted Cash Flow Growth 14.00%
Forecasted Earnings Growth 8.56%
Forecasted Revenue Growth 7.08%
As of Feb. 29, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 9/20/2010
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 12/20/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.